Recruiting Atrial Fibrillation Studies in Lancaster
About Atrial Fibrillation Clinical Trials in Lancaster
Atrial fibrillation (AFib) is the most common type of heart arrhythmia, causing an irregular and often rapid heartbeat. It significantly increases the risk of stroke, heart failure, and other complications. Treatment includes blood thinners, heart rate or rhythm control medications, and procedures like ablation.
There are currently 1 atrial fibrillation clinical trials recruiting participants in Lancaster, PENNSYLVANIA. These studies are seeking a combined 1,900 participants. Research is being sponsored by Anthos Therapeutics, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Atrial Fibrillation Clinical Trials in Lancaster — FAQ
Are there atrial fibrillation clinical trials in Lancaster?
Yes, there are 1 atrial fibrillation clinical trials currently recruiting in Lancaster, PENNSYLVANIA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Lancaster?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Lancaster research site will contact you about next steps.
Are clinical trials in Lancaster free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Lancaster studies also compensate for your time and travel.
What atrial fibrillation treatments are being tested?
The 1 active trials in Lancaster are testing new therapies including novel drugs, biologics, and treatment approaches for atrial fibrillation.
Data updated March 2, 2026 from ClinicalTrials.gov